Kelly Paschke, DO
Interventional Cardiology · Honolulu, HINPI 1205221827
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,788 of the $6,974 with a category attached, or 83.0%. 13 manufacturers reported payments, led by Edwards Lifesciences at 36.7% of the total. 2025 is the largest year on record at $2,695, more than ten times the $258 reported in 2021.
Across 77 payments — averaging $90.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Shockwave Medical, Inc$1K
- Abiomed$1K
- Abbott$726
- Teleflex LLC$249
- Boston Scientific$190
- plus $600 from 7 others
What the payments were for
- Travel & lodging$1,18517%
- Food & beverage$5,78883%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 27 | $2,561 |
| Shockwave Medical, Inc | 10 | $1,440 |
| Abiomed | 18 | $1,208 |
| Abbott | 7 | $726 |
| Teleflex LLC | 2 | $249 |
| Boston Scientific | 2 | $190 |
| Heartflow, Inc. | 1 | $166 |
| Cardiovascular Systems Inc. | 1 | $148 |
| Chiesi USA, Inc. | 1 | $79 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $63 |
| Johnson & Johnson | 2 | $58 |
| Cathworks, Inc. | 1 | $45 |
| Cvrx, Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$1,725
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,313
- Impella$668
- GUIDELINER$249
- FFRct$166
- PORTICO$163
- OPTICROSS$150
- DRAGONFLY OPSTAR$149
- Diamondback Coronary$148
- COROFLOW$113
- NAVITOR$111
How this compares
Too few interventional cardiology providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 40 | $30,195 |
| Atorvastatin Calcium | 67 | $2,503 |
| ClopidogrelClopidogrel Bisulfate | 47 | $1,537 |
| Amlodipine Besylate | 36 | $525 |
| Losartan Potassium | 36 | $494 |
| Metoprolol Succinate | 37 | $435 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 26 | $363 |
| Carvedilol | 19 | $210 |
| Furosemide | 13 | $17 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Honolulu
- John CoganHonolulu$82K
- Kris KawamotoHonolulu$25K
- Giselle Baquero CaranamaHonolulu$20K
- Atsushi TerakuboHonolulu$20K
- John KaoHonolulu$6K
- John O'MaraHonolulu$5K
- Brandon KaiHonolulu$3K
- Jay GadgilHonolulu$2K
- Marie NguyenHonolulu$189
- Jason CallWailuku$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.